Insider Transactions in Q4 2024 at Mirum Pharmaceuticals, Inc. (MIRM)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 14
2024
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
2,500
-50.75%
|
$117,500
$47.1 P/Share
|
|
Nov 14
2024
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+33.67%
|
$5,000
$2.94 P/Share
|
|
Nov 08
2024
|
Joanne Quan CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
118
+50.0%
|
$2,478
$21.05 P/Share
|
|
Nov 08
2024
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
65
+0.05%
|
$1,365
$21.05 P/Share
|
|
Nov 08
2024
|
Eric Bjerkholt CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
475
+1.41%
|
$9,975
$21.05 P/Share
|